A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack
Marie Viprey,1,2 Maïlys Gouillet,3 Costanza Puppo,3 Anne Termoz,1,2 Claire Della Vecchia,2,3 Laurent Derex,2,4 Julie Haesebaert,1,2 Anne-Marie Schott,1,2 Marie Préau3 1Public Health Department, Hospices Civils de Lyon, Lyon, France; 2HESPER EA 7425, University of Lyon, University...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-07-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/a-qualitative-study-of-barriers-and-facilitators-to-adherence-to-secon-peer-reviewed-article-PPA |
_version_ | 1818134240158547968 |
---|---|
author | Viprey M Gouillet M Puppo C Termoz A Della Vecchia C Derex L Haesebaert J Schott AM Préau M |
author_facet | Viprey M Gouillet M Puppo C Termoz A Della Vecchia C Derex L Haesebaert J Schott AM Préau M |
author_sort | Viprey M |
collection | DOAJ |
description | Marie Viprey,1,2 Maïlys Gouillet,3 Costanza Puppo,3 Anne Termoz,1,2 Claire Della Vecchia,2,3 Laurent Derex,2,4 Julie Haesebaert,1,2 Anne-Marie Schott,1,2 Marie Préau3 1Public Health Department, Hospices Civils de Lyon, Lyon, France; 2HESPER EA 7425, University of Lyon, University Claude Bernard Lyon 1, Lyon, France; 3GRePS, Lyon 2 University, Lyon, France; 4Comprehensive Stroke Center, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, FranceCorrespondence: Marie VipreyHospices Civils de Lyon, Pôle de Santé Publique, Bâtiment A, 6ème étage, 162, Avenue Lacassagne, Lyon 69003, FranceTel +33 4 72 11 53 02Email marie.viprey@chu-lyon.frPurpose: Secondary prevention medications (SPM) reduce the risk of ischemic stroke (IS) and transient ischemic attack (TIA) recurrence. However, approximately one-third of patients are estimated to be non-adherent. This qualitative study aimed to explore barriers and facilitators to adherence to SPM after IS or TIA.Patients and Methods: Thirty-six face-to-face semi-structured interviews were conducted with 14 TIA patients and 22 IS patients who self-administered their treatment 12 months after IS/TIA. A thematic analysis was performed.Results: Major facilitators to good adherence to SPM were the fear of stroke recurrence and the high level of trust in the prescribing physician. Barriers included a perceived lack and/or inappropriate timing of information about SPM, practical difficulties of taking some SPM (eg, inadequate packaging) and of implementing routines into their daily life.Conclusion: Information on SPM is inadequate in terms of quantity and timing both during the acute IS/TIA period and over the long term. Providing more tailor-made information at an opportune moment, in particular by promoting discussion with their general practitioner (GP) throughout the course of illness and recovery, is essential to ensure that patients are not left alone in the decision-making process regarding adherence to SPM.Keywords: medication adherence, stroke, transient ischemic attack, qualitative study |
first_indexed | 2024-12-11T09:05:28Z |
format | Article |
id | doaj.art-6957d28699414143976ecf979665213e |
institution | Directory Open Access Journal |
issn | 1177-889X |
language | English |
last_indexed | 2024-12-11T09:05:28Z |
publishDate | 2020-07-01 |
publisher | Dove Medical Press |
record_format | Article |
series | Patient Preference and Adherence |
spelling | doaj.art-6957d28699414143976ecf979665213e2022-12-22T01:13:39ZengDove Medical PressPatient Preference and Adherence1177-889X2020-07-01Volume 141213122355519A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic AttackViprey MGouillet MPuppo CTermoz ADella Vecchia CDerex LHaesebaert JSchott AMPréau MMarie Viprey,1,2 Maïlys Gouillet,3 Costanza Puppo,3 Anne Termoz,1,2 Claire Della Vecchia,2,3 Laurent Derex,2,4 Julie Haesebaert,1,2 Anne-Marie Schott,1,2 Marie Préau3 1Public Health Department, Hospices Civils de Lyon, Lyon, France; 2HESPER EA 7425, University of Lyon, University Claude Bernard Lyon 1, Lyon, France; 3GRePS, Lyon 2 University, Lyon, France; 4Comprehensive Stroke Center, Pierre Wertheimer Hospital, Hospices Civils de Lyon, Bron, FranceCorrespondence: Marie VipreyHospices Civils de Lyon, Pôle de Santé Publique, Bâtiment A, 6ème étage, 162, Avenue Lacassagne, Lyon 69003, FranceTel +33 4 72 11 53 02Email marie.viprey@chu-lyon.frPurpose: Secondary prevention medications (SPM) reduce the risk of ischemic stroke (IS) and transient ischemic attack (TIA) recurrence. However, approximately one-third of patients are estimated to be non-adherent. This qualitative study aimed to explore barriers and facilitators to adherence to SPM after IS or TIA.Patients and Methods: Thirty-six face-to-face semi-structured interviews were conducted with 14 TIA patients and 22 IS patients who self-administered their treatment 12 months after IS/TIA. A thematic analysis was performed.Results: Major facilitators to good adherence to SPM were the fear of stroke recurrence and the high level of trust in the prescribing physician. Barriers included a perceived lack and/or inappropriate timing of information about SPM, practical difficulties of taking some SPM (eg, inadequate packaging) and of implementing routines into their daily life.Conclusion: Information on SPM is inadequate in terms of quantity and timing both during the acute IS/TIA period and over the long term. Providing more tailor-made information at an opportune moment, in particular by promoting discussion with their general practitioner (GP) throughout the course of illness and recovery, is essential to ensure that patients are not left alone in the decision-making process regarding adherence to SPM.Keywords: medication adherence, stroke, transient ischemic attack, qualitative studyhttps://www.dovepress.com/a-qualitative-study-of-barriers-and-facilitators-to-adherence-to-secon-peer-reviewed-article-PPAmedication adherencestroketransient ischemic attackqualitative study |
spellingShingle | Viprey M Gouillet M Puppo C Termoz A Della Vecchia C Derex L Haesebaert J Schott AM Préau M A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack Patient Preference and Adherence medication adherence stroke transient ischemic attack qualitative study |
title | A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack |
title_full | A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack |
title_fullStr | A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack |
title_full_unstemmed | A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack |
title_short | A Qualitative Study of Barriers and Facilitators to Adherence to Secondary Prevention Medications Among French Patients Suffering from Stroke and Transient Ischemic Attack |
title_sort | qualitative study of barriers and facilitators to adherence to secondary prevention medications among french patients suffering from stroke and transient ischemic attack |
topic | medication adherence stroke transient ischemic attack qualitative study |
url | https://www.dovepress.com/a-qualitative-study-of-barriers-and-facilitators-to-adherence-to-secon-peer-reviewed-article-PPA |
work_keys_str_mv | AT vipreym aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT gouilletm aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT puppoc aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT termoza aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT dellavecchiac aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT derexl aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT haesebaertj aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT schottam aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT preaum aqualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT vipreym qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT gouilletm qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT puppoc qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT termoza qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT dellavecchiac qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT derexl qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT haesebaertj qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT schottam qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack AT preaum qualitativestudyofbarriersandfacilitatorstoadherencetosecondarypreventionmedicationsamongfrenchpatientssufferingfromstrokeandtransientischemicattack |